Search database
LIST OPTIONS
Filter
23
Filtered Results: 23
Text search: 1 A Pharma GmbH
Featured
Language
Document type
No document type
15
Studies & Reports
4
Manuals
2
Training Material
1
Fact sheets
1
Countries / Regions
Germany
4
Russia
3
Western and Central Europe
2
Global
2
Ethiopia
1
Uganda
1
India
1
Syria
1
Bangladesh
1
Ukraine
1
Madagascar
1
Eastern Europe
1
Authors & Publishers
1 A Pharma
4
1 A Pharma GmbH
3
A. S. Brand
2
A. Sandoz Brand
2
Bousquet, J.
2
BUKO Pharma-Kampagne
2
Khaltaev, N.
2
World Health Organization WHO
2
Agence du Médicament de Madagascar
1
Bauersachs, J.
1
Berliner, D.
1
Bozorgmehr, K.
1
Bundeszentrale für gesundheitliche Aufklärung
1
Deutsche Hauptstelle für Suchtfragen e.V.
1
Deutsche Zusammenarbeit
1
Deutsches Ärzteblatt International
1
Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh
1
Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA)
1
German Cooperation
1
Hänselmann, A.
1
Médecins Sans Frontières (MSF)
1
Paul-Ehrlich-Institu PEI
1
Pharma-Ed
1
Preussler, S.
1
R. Gaßmann
1
Unitaid
1
Wagner, U. et al.
1
Publication Years
Category
Countries
5
Public Health
2
Clinical Guidelines
2
Women & Child Health
1
Pharmacy & Technologies
1
Toolboxes
Mental Health
9
NCDs
3
COVID-19
2
Pharmacy
2
Disability
1
TB
1
Общая и научная информация, содержащаяся в данном справочнике, соответствует современному уровню знаний на момент подготовки издания (см. информацию на обороте). ... more
По данным информационного центра «Эпилепсия» (ize) Немецкого общества эпилептологии, от 400 000 до 800 000 людей в Германии страдают эпилепсией. Медики говорят об эпилепси... more
Данная информация для пациентов основана на последних научных разработках. Она обобщает важнейшие пункты рекомендаций для пациентов на тему "Болезнь Паркинсона".
The Guide
Le guide
Le guide Ratgeber Parkinson – Französisch Accessed: 11.03.2019
The Guide Ratgeber Parkinson – Englisch Accessed: 11.03.2019
Chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease, kill more than four million people every year and affect hundreds of millions more. These diseases erode the health and well-being of the patients and have a... more
Screening programmes for tuberculosis (TB) among immigrants rarely consider the heterogeneity of risk related to migrants’ country of origin. We assess the performance of a large screening programme in asylum seekers by analysing (i) the differen... more
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Date : 15.07.2015 Test enzymatique sur bandelettes pour le dosage semi-quantitatif de l’H2O2
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Background Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.... more
Über SARS-CoV-2-Testsysteme informieren das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und das Paul-Ehrlich-Institut. Die Informationen ergänzen sich, den rechtlichen Rahmen bietet u.a. die Coronavirus-Testverordnung-TestV. Da... more
Chronic respiratory diseases, such as asthma and chronic obstructive pulmonary disease, kill more than four million people every year and affect hundreds of millions more. These diseases erode the health and well-being of the patients and have a... more
This paper was commissioned by the German Federal Ministry for Economic Cooperation and Development (BMZ) in 2015, and produced by the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, in cooperation with German civil society acto... more
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to... more